Table 29.1 Studies done in animal models to investigate the hepatoprotective actions of bioactive compounds isolated from different plant species
Plant spp. used
Dose (mg/kg), admin.
route
Animal models
Possible mechanism of action
Reference
Allium sativum
300 mg/kg for
14 days, i.p.
Male Wistar rats, D-galactosamine and
lipopolysaccharide (DGaIN/LPS)-
induced hepatotoxicity
Antioxidant defence system
El-Beshbishy (2008)
Allium hirtifolium
0.1 and 1 g/kg, i.p.
Wistar rats, alloxan-induced diabetes
and liver damage
By the reduction of liver cell damage and
also through hypoglycaemic and
hypolipidaemic activities and thereby
preventing fatty liver formation
Kazemi et al. (2010)
Andrographis
paniculata
100 mg/kg, i.p.
Wistar rats, CCl4-induced
hepatotoxicity
By decreasing the oxidative stress
Handa and Sharma
(1990)
Apium graveolens
200 mg/kg p.o.
Porton albino rats, paracetamol and
thioacetamide-induced hepatotoxicity
Might be due to activation of
reticuloendothelial system functions or
inhibition of protein biosynthesis
Singh and Handa
(1995)
Hygrophila
auriculata
200 mg/kg p.o.
Porton albino rats, paracetamol and
thioacetamide-induced hepatotoxicity
Might be due to activation of
reticuloendothelial system functions or
inhibition of protein biosynthesis
Singh and Handa
(1995)
Asparagus
racemosus
150 and 300 mg/kg, s.
c.
Wistar rats, CCl4-induced
hepatotoxicity
Due to antioxidant activity of flavonoids
Acharya et al. (2012)
Berberis vulgaris
(berberine)
80, 120 and 160 mg/
kg, orally
Male Sprague-Dawley rats, CCl4-
induced acute liver damage
Not known
Feng et al. (2010)
Boerhaavia
diffusa
2 mLkg, orally
Male albino rats, thioacetamide-
induced hepatotoxicity
Membrane stabilising effects
Rawat et al. (1997)
Crocus sativus
20 mg/kg, orally
Male Wistar rats, acetyl-para-
aminophenol (APAP)-induced
hepatotoxicity
Might be due to the presence of flavonoids
and their antioxidant properties
Omidi et al. (2014)
Curcuma longa
250 and 500 mg/kg,
orally
Sprague Dawley rats, thioacetamide-
induced hepatotoxicity
Might be due to direct antioxidant and free
radical scavenging mechanisms
Salama et al. (2013)
(continued)
29
The Pathophysiology of Liver Disorders and Pharmacotherapy Options with. . .
553